Admedus is a structural heart company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Its focus is on investing in and developing next generation technologies with world class partners and acquiring strategic assets to grow product and service offerings. The company has assets from research & development through clinical development and sales, marketing and distribution.


LATEST NEWS


FIRST-IN-HUMAN SAVR TRIAL BEGINS Q1 2020
ANNOUNCEMENT FIRST-IN-HUMAN SAVR TRIAL BEGINS Q1 2020 Admedus Limited (AHZ or the Company) announces approval for first-in-human surgical aortic valve...
Read more.

Admedus has announced Ethics Committee approval at Leuven Univ Hospital for the human trial of its #ADAPT 3D single… https://t.co/gkyggrd4ox
“What we have is actually novel and unique. There is only one #ADAPT® process.” Don’t miss CEO Wayne Paterson full… https://t.co/MrvUlDyd4I
CEO Wayne Paterson presents the benefits of our superior tissue science (TS) and unique single piece valve design (… https://t.co/1WKVKtUWt1